Mary E Wilkerson-Brinsko - FDA Investigator Report

Overview Statistics

70
Total Inspections
40
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 9 days
Shortest Inspection: 1 days
Average Length: 0.5 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Mary E Wilkerson-Brinsko's Recent Inspections

DateCompanyCityCountryFEI Number483
2013-05-22Stanford Clinical Laboratory at HillviewPalo AltoUnited States3005404232
2013-05-15Stanford Healthcare ValleyCarePleasantonUnited States3006987813
2013-04-23Bruce A. Buckingham, M.D.Palo AltoUnited States3003659176
2013-04-12Berkeley Advanced Biomaterials, Inc.BerkeleyUnited States3003586733
2013-03-01Titan Pharmaceuticals IncSouth San FranciscoUnited States3003415553
2013-02-06Fairfax Cryobank, Inc.San FranciscoUnited States3003110346
2013-01-15Reproductive Science Center of the Bay AreaOrindaUnited States3007376346
2013-01-09Children's Hospital and Research Center at OaklandOaklandUnited States2971437
2012-12-12University of California, Davis Med Center Blood BankSacramentoUnited States2972222
2012-12-05BloodSource, Inc.AuburnUnited States1000123568

Sign Up to get the complete report.

Download 483s and EIRs for Mary E Wilkerson-Brinsko

Mary E Wilkerson-Brinsko - Co-Inspectors

NameInspectionsLast Inspection
Jennifer H Rhyu22013
Virgilio F Pacio22008
Robert S Sweeton12009
Joey V Quitania12009
Yvette E Guillermo12008

Mary E Wilkerson-Brinsko's Active Locations

  • United States
  • India

Mary E Wilkerson-Brinsko's Year-wise Inspection Count

  • 2008:13 inspections
  • 2009:11 inspections
  • 2010:13 inspections
  • 2011:11 inspections
  • 2012:14 inspections
  • 2013:8 inspections
Last Updated: 2025-05-14 06:11:22